Skip to main content
N

Novuson

Novuson develops patented Direct Therapeutic Ultrasound (DTU) technology for advanced energy applications in surgery. This innovation targets vessel sealing, dividing, soft tissue ablation, and hemostasis without passing electric current through the patient. Their device portfolio includes specialized sealers and dividers designed to improve efficiency and patient outcomes in surgical and trauma settings.

Bothell, United StatesFounded 20149500+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Traditional surgical tools for vessel sealing and hemostasis often rely on electrical current, which can pose risks to patients and may not be optimal for all tissue types. Existing methods can also be time-consuming, potentially leading to increased blood loss and longer procedure durations.

Solution

Novuson has developed Direct Therapeutic Ultrasound (DTU) technology, a novel approach to vessel sealing, soft tissue ablation, and hemostasis in surgical and trauma procedures. DTU utilizes focused ultrasound energy to precisely target tissue without passing electric current through the patient, offering a safer and more efficient alternative to traditional methods. The technology aims to improve patient outcomes by enabling clinicians to quickly control bleeding, reduce surgical time, and minimize the need for blood transfusions. Novuson's DTU platform includes a range of instruments designed for various surgical applications, including minimally invasive procedures and open surgery.

Target Audience

The primary target audience includes surgeons and medical professionals in hospitals and surgical centers who perform vessel sealing, soft tissue ablation, and hemostasis procedures.

Features

  • Direct Therapeutic Ultrasound (DTU) technology uses focused ultrasound energy for precise tissue interaction.
  • 3mm Mini LS instrument capable of sealing and dividing vessels up to 7mm, designed for minimally invasive surgery.
  • 10mm UltraStat MAXX instrument designed for thick tissue and organ hemostasis.
  • Non-electrical energy delivery eliminates the risk of electrical current passing through the patient.
This profile is AI-generated and may contain inaccuracies.